Author Question: The A-B-A-B design is a slight variation on the A-B-A design, in which treatment is returned at the ... (Read 65 times)

melly21297

  • Hero Member
  • *****
  • Posts: 565
The A-B-A-B design is a slight variation on the A-B-A design, in which treatment is returned at the end of the experiment. Under what conditions would this be most desirable?
 
  a. if the researcher is still not sure whether the treatment was effective
   b. if the treatment has some beneficial therapeutic effect
  c. if the treatment did not produce the desired effect the first time it was presented
  d. if the participant enjoyed the treatment

Question 2

A potential ethical problem with using the A-B-A design in a therapeutic context is that it
 
  a. does not seem to be useful for certain kinds of disorders.
   b. entails ending in a non-treatment condition.
  c. often aggravates the problem the treatment is meant to treat.
  d. does not involve enough time in treatment to address all a behavior.



atrochim

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

B

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Your skin wrinkles if you stay in the bathtub a long time because the outermost layer of skin (which consists of dead keratin) swells when it absorbs water. It is tightly attached to the skin below it, so it compensates for the increased area by wrinkling. This happens to the hands and feet because they have the thickest layer of dead keratin cells.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library